<- Go Home
GenoMed, Inc.
GenoMed, Inc., a development stage biotechnology company, operates in the medical genomics field. The company markets its protocols to prevent kidney failure due to high blood pressure and diabetes, and to delay the progression of emphysema. It also develops treatment products for four diseases, including diabetes, hypertension, emphysema, and psoriasis. GenoMed, Inc. was founded in 2001 and is based in St. Leesburg, Florida.
Market Cap
$197.2K
Volume
745.7K
Cash and Equivalents
$274.1K
EBITDA
$1.1M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$4.7K
Profit Margin
100.00%
52 Week High
$0.01
52 Week Low
$0.00
Dividend
N/A
Price / Book Value
6.94
Price / Earnings
0.22
Price / Tangible Book Value
6.94
Enterprise Value
N/A
Enterprise Value / EBITDA
N/A
Operating Income
$1.1M
Return on Equity
148.43%
Return on Assets
65.22
Cash and Short Term Investments
$274.1K
Debt
N/A
Equity
$28.4K
Revenue
$4.7K
Unlevered FCF
$823.4K
Sector
Biotechnology
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium